Kymera Therapeutics Inc (KYMR)
43.51
-0.54
(-1.23%)
USD |
NASDAQ |
Nov 21, 16:00
43.56
+0.05
(+0.11%)
Pre-Market: 20:00
Kymera Therapeutics Profit Margin (Quarterly): -1.67K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.67K% |
| June 30, 2024 | -164.0% |
| March 31, 2024 | -472.0% |
| December 31, 2023 | -30.01% |
| September 30, 2023 | -1.12K% |
| June 30, 2023 | -235.0% |
| March 31, 2023 | -432.4% |
| December 31, 2022 | -216.0% |
| September 30, 2022 | -450.2% |
| June 30, 2022 | -349.6% |
| March 31, 2022 | -381.3% |
| Date | Value |
|---|---|
| December 31, 2021 | -221.9% |
| September 30, 2021 | -140.5% |
| June 30, 2021 | -133.2% |
| March 31, 2021 | -69.91% |
| December 31, 2020 | -99.22% |
| September 30, 2020 | -54.95% |
| June 30, 2020 | -425.5% |
| March 31, 2020 | -318.9% |
| December 31, 2019 | -628.1% |
| September 30, 2019 | -1.20K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.67K%
Minimum
Sep 2024
-30.01%
Maximum
Dec 2023
-380.6%
Average
-276.9%
Median
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 33.28% |
| Voyager Therapeutics Inc | -36.72% |
| Denali Therapeutics Inc | -- |
| Vir Biotechnology Inc | -73.95K% |
| Avidity Biosciences Inc | -3.44K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.19% |
| Return on Assets | -21.71% |
| Return on Invested Capital | -27.19% |
| Operating Margin (Quarterly) | -1.93K% |
| Return on Net Operating Assets | -161.6% |